AstraZeneca plans to outsource 100% of its API manufacturing within seven years, it told analysts at a recent briefing. The company currently outsources about 80% of its API manufacturing with three preferred suppliers in Europe and suppliers in India. The additional outsourcing is expected to come from India where the cost base is lower, said Executive Vice President for Operations, David Smith, although the company expects to introduce greater quality control and supplier audits.
AstraZeneca
Thursday, 26 November 2009
AZ to out source all API manufacturing
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment